ArticleFrontiers in immunology2026
Que/n-HA/PGCL microspheres orchestrate bone repair via context-dependent osteoimmune mechanisms: a transcriptomic dissection of direct and immune-mediated signaling.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bone defect repair remains a clinical challenge due to the complex inflammatory microenvironment that regulates mesenchymal stem cell fate. Methods: Based on our previous work demonstrating that quercetin-loaded n-HA/PGCL (Que/n-HA/PGCL) nanocomposite microspheres promote bone repair via immunoregulation and osteogenesis, the present study employs RNA-seq and Western blot validation to elucidate the transcriptomic mechanisms by which these microspheres differentially regulate bone marrow mesenchymal stem cells (BMSCs) in direct versus immune-mediated microenvironments. Using a Transwell co-culture system, we simulated two distinct conditions: direct BMSC-microsphere interaction and BMSC culture with microsphere-modulated RAW264.7 macrophages. Results: RNA-seq and Western blot analyses revealed context-dependent pathway activation: direct Que/n-HA/PGCL treatment activated PI3K-Akt/MAPK signaling in BMSCs, while immune-mediated conditions activated Ras/MAPK and TGF-β/Smad pathways via macrophage modulation. Discussion and conclusion: By identifying the context-dependent activation of PI3K-Akt/MAPK pathways in direct BMSC interaction and Ras/MAPK/TGF-β/Smad pathways in immune-mediated scenarios, this work offers a mechanistic blueprint for the development of intelligent bone repair materials. The success of bone defect repair is intricately linked to the complex inflammatory microenvironment, which dictates the fate of mesenchymal stem cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.